洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2500114232】Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial

基本信息
登记号

ChiCTR2500114232

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-12-09

临床申请受理号

/

靶点

/

适应症

End-stage renal disease (ESRD) on maintenance hemodialysis

试验通俗题目

Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial

试验专业题目

Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1.To evaluate the effect of a combination stress ball and lavender oil on pain during arteriovenous cannulation in hemodialysis patients. 2.To evaluate the effect of a combination stress ball and lavender oil on anxiety during arteriovenous cannulation in hemodialysis patients.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Simple randomization was used based on the pre-assigned hemodialysis schedule. Patients attending sessions on Saturday, Monday, and Wednesday were allocated to the intervention group, while those dialyzing on Sunday, Tuesday, and Thursday were assigned to the control group. The allocation process was not influenced by the researcher; the distribution was determined naturally by the dialysis unit schedule. A nurse from the dialysis unit, who was not involved in the intervention or outcome assessment, supervised the grouping process to ensure unbiased and independent allocation.

盲法

Single-blind (participant-blind) study. Participants were unaware of their group allocation, while the nurse collecting outcome data was not involved in delivering the intervention to ensure unbiased assessment.

试验项目经费来源

Self-funded by the investigator

试验范围

/

目标入组人数

40

实际入组人数

/

第一例入组时间

2025-12-08

试验终止时间

2026-03-07

是否属于一致性

/

入选标准

1. The subject must be 18 years of age or older. 2. Be receiving regular and continuous hemodialysis sessions via a valid vascular access (fistula) at least three months 3. Be able to understand the study details, provide informed consent, and accurately report their own pain or anxiety levels. 4. Have sufficient physical ability to use a stress ball in the hand or limb opposite their vascular access site. 5. Have no known allergies to lavender oil or its carrier ingredient. They must also be free of any active respiratory conditions that could be affected by inhaling the scent.;

排除标准

1. Have a history of allergic reactions to lavender oil or any components of the preparation used in this study. 2. Have an active infection or severe complication at the vascular access site, or any other unstable medical condition that could place the participant at increased risk. 3. Taking painkillers, sedatives, or anti-anxiety medications during three-hour prior HD 4. Severe cognitive impairment, severe psychiatric disorder, or language impairment that impedes informed consent or reliable self-reporting. 5. Physical inability to use a stress ball (such as amputation or paralysis), or any other condition that the study administrators deem a contraindication to participation.;

研究者信息
研究负责人姓名
请登录查看
试验机构

College of Nursing, University of Baghdad

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用